Most Recent Analysts Ratings AstraZeneca PLC (AZN)


AstraZeneca PLC (AZN) will report its next earnings on Nov 09 BMO. The company reported the earnings of $0.56/Share in the last quarter where the estimated EPS by analysts was $0.55/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 1.8%.

Many analysts are providing their Estimated Earnings analysis for AstraZeneca PLC and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $0.45/share. These analysts have also projected a Low Estimate of $0.38/share and a High Estimate of $0.53/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for AstraZeneca PLC as 5.48 Billion. According to these analysts, the Low Revenue Estimate for AstraZeneca PLC is 5.26 Billion and the High Revenue Estimate is 5.79 Billion. The company had Year Ago Sales of 5.58 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for AZN to be -26.2%. They are projecting Next Quarter growth of -32%. For the next 5 years, AstraZeneca PLC is expecting Growth of 6.8% per annum, whereas in the past 5 years the growth was -5.16% per annum.

Some buy side analysts are also providing their Analysis on AstraZeneca PLC, where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for AstraZeneca PLC might touch $50.17 high while the Average Price Target and Low price Target is $35.42 and $24.92 respectively.

The Relative Volume of the company is 0.82 and Average Volume (3 months) is 4.07 million. The company’s P/E (price to earnings) ratio is 23.02 and Forward P/E ratio of 20.05.

The company shows its Return on Assets (ROA) value of 5.6%. The Return on Equity (ROE) value stands at 25.7%. While it’s Return on Investment (ROI) value is 15%.

While looking at the Stock’s Performance, AstraZeneca PLC currently shows a Weekly Performance of -3.94%, where Monthly Performance is -6.61%, Quarterly performance is 6.13%, 6 Months performance is -7.68% and yearly performance percentage is 24.71%. Year to Date performance value (YTD perf) value is 17.86%. The Stock currently has a Weekly Volatility of 1.47% and Monthly Volatility of 1.08%.